NCT03526302 (TROPIC) is a clinical trial in Sudden Cardiac Death, sponsored by Deutsches Herzzentrum Muenchen.

Who is sponsoring NCT03526302?

NCT03526302 is sponsored by Deutsches Herzzentrum Muenchen.

What condition does NCT03526302 study?

NCT03526302 studies Sudden Cardiac Death.

Is NCT03526302 still recruiting?

NCT03526302 is currently completed. Last updated 20 March 2023.

Last reviewed 2023-03-20 · How we verify

NCT03526302: TROPIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation

Completed Last updated 20 March 2023

What this trial tests

trial in Sudden Cardiac Death in 43 participants. Completed in 30 September 2020.

Timeline

1 April 2018

Primary endpoint
30 September 2020

30 September 2020

Quick facts

Lead sponsor	Deutsches Herzzentrum Muenchen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	43
Start date	1 April 2018
Primary completion	30 September 2020
Estimated completion	30 September 2020
Sites	1 location across Germany

Conditions studied

Sudden Cardiac Death — all drugs for Sudden Cardiac Death →

Sponsor

Deutsches Herzzentrum Muenchen — full company profile →

Who can join

18 and older, any sex, with Sudden Cardiac Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Serum Troponin levels pre- and postoperatively will be compared in patients receiving an entirely subcutaneous cardioverter-defibrillator.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sudden Cardiac Death

Currently open trials in the same condition.

NCT07372196 — Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy · NA · recruiting
NCT06964464 — Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardio · Phase 4 · recruiting
NCT06546137 — National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un · recruiting
NCT06771700 — S-ICD Implantation: US Based Pilot Study · NA · recruiting
NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting

Other Deutsches Herzzentrum Muenchen trials

Trials by the same sponsor.

NCT07344480 — Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM) · recruiting
NCT06369142 — Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy · NA · recruiting
NCT06753227 — Invasive Versus Echocardiography-derived Transvalvular Gradients After TAVI Usign Balloon-expandable Transcatheter Heart · enrolling by invitation
NCT06814574 — Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement · recruiting
NCT06060912 — LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526302 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deutsches Herzzentrum Muenchen
Last refreshed: 20 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing